Pfizer Limited (BOM:500680)
India · Delayed Price · Currency is INR 4,062.05
-34.20 (-0.83%)
At close: Sep 11, 2026
Pfizer Market Cap
Pfizer has a market cap or net worth of 185.74 billion as of September 14, 2026. Its market cap has decreased by -21.02% in one year.
Market Cap
185.74B
Enterprise Value
155.56B
Revenue
25.70B
Ranking
n/a
PE Ratio
25.27
Stock Price
4,062.05
ChartMarket Cap Chart
Since March 12, 1999, Pfizer's market cap has increased from 33.02B to 185.74B, an increase of 462.60%. That is a compound annual growth rate of 6.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 185.74B | -18.60% |
| Dec 31, 2025 | 228.18B | -5.56% |
| Dec 31, 2024 | 241.62B | 23.72% |
| Dec 29, 2023 | 195.29B | -3.67% |
| Dec 30, 2022 | 202.74B | -12.34% |
| Dec 31, 2021 | 231.27B | -1.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pharmaceuticals | 480.64B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Granules India | 225.41B |
| Caplin Point Laboratories | 209.39B |
| AstraZeneca Pharma India | 169.63B |
| Jubilant Pharmova | 162.36B |
| Viyash Scientific | 112.28B |
| Procter & Gamble Health | 89.81B |